EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silymarin and Zinc Oxide Nanoparticles Attenuate Experimental Colon Cancer in Rats Through Crosstalk of miR-192 and β-Catenin Pathways

Eman H Yousef iD, Aya Megahed iD, Alaa Samy iD, Amgad E Salem, Jawaher Abdullah Alamoudi iD, Ahmed Abbas, Eman M Embaby

Biomolecules · 2026

DOI: 10.3390/biom16091374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Eman H Yousef und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt. Hauptthemen laut MEDLINE: Silymarin, Zinc Oxide, MicroRNAs, beta Catenin. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer (CC) is a leading cause of cancer-related mortality globally. Although chemotherapy remains the primary treatment, its toxicity and drug resistance highlight the need for alternative therapeutic strategies. Silymarin (Sily), a natural compound, and zinc oxide nanoparticles (ZnO-NPs) have shown potential antitumor activity. This study evaluated Sily and/or ZnO-NPs against DMH-induced CC in rats. Thirty male Sprague-Dawley rats were divided into five groups (n = 6): control, CC (DMH 20 mg/kg/16-week S.C.), and three groups receiving Sily (40 mg/kg orally), ZnO-NPs (10 mg/kg IP), or their combination daily for 4 weeks. In comparison to the CC group, Sily or ZnO-NPs significantly decreased CEA levels, restored mucin synthesis, and improved colonic histology, with the combination treatment producing the most pronounced antitumor effects. Treatments attenuated oxidative stress, with Sily restoring SOD and GSH levels, whereas ZnO-NPs primarily reduced lipid peroxidation, as reflected by decreased MDA levels. Mechanistically, the combined therapy decreased inhibitory GSK-3β phosphorylation and β-catenin expression, consistent with restoration of GSK-3β-mediated suppression of β-catenin. The combination also restored PKCα and miR-192 expression and reduced the expression of the proliferation- and metastasis-associated markers MMP-9, c-Myc, and Cyclin-D1. CD133 expression was significantly reduced, suggesting an effect on the cancer stem cell-associated phenotype. Sily and ZnO-NPs demonstrated therapeutic effects against CC, particularly when administered in combination. Their antitumor effects were associated with modulation of miR-192/PKCα and GSK-3β/β-catenin signaling, supporting further investigation of their combined multitargeted potential in CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SilymarinZinc OxideMicroRNAsbeta CateninColonic NeoplasmsNanoparticlesAnimalsMaleRatsRats, Sprague-DawleyOxidative StressAntineoplastic AgentsGlycogen Synthase Kinase 3 beta

Stichwörter der Autor:innen

MicroRNAsSilymarincolon cancernanoparticleszinc oxideβ-catenin

Substanzen

SilymarinZinc OxideMicroRNAsbeta CateninAntineoplastic AgentsGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Department of Clinical Pathology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
  • Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.

ORCID-Profile: Eman H Yousef, Aya Megahed, Alaa Samy, Jawaher Abdullah Alamoudi

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Yousef, E. H., Megahed, A., Samy, A., Salem, A. E., Alamoudi, J. A., Abbas, A., & Embaby, E. M. (2026). Silymarin and Zinc Oxide Nanoparticles Attenuate Experimental Colon Cancer in Rats Through Crosstalk of miR-192 and β-Catenin Pathways. Biomolecules. https://doi.org/10.3390/biom16091374

Vancouver

Yousef EH, Megahed A, Samy A, Salem AE, Alamoudi JA, Abbas A, et al. Silymarin and Zinc Oxide Nanoparticles Attenuate Experimental Colon Cancer in Rats Through Crosstalk of miR-192 and β-Catenin Pathways. Biomolecules. 2026. doi:10.3390/biom16091374

BibTeX
@article{Yousef2026,
  author = {Yousef, Eman H and Megahed, Aya and Samy, Alaa and Salem, Amgad E and Alamoudi, Jawaher Abdullah and Abbas, Ahmed and Embaby, Eman M},
  title = {Silymarin and Zinc Oxide Nanoparticles Attenuate Experimental Colon Cancer in Rats Through Crosstalk of miR-192 and β-Catenin Pathways},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091374}
}
Kostenlos starten →